noom glp 1 companion Doximity Noom expands its GLP-1 range

[Pubmed] [Wiley] [Pubmed] National Research Council (US) Subcommittee on the Tenth Edition of the Recommended Dietary Allowances

One thing I teach my GLP-1 clients (and practice myself) is why we snack

Long-term sustainability factors include cost, convenience, and results timeline

Microbial imidazole propionate affects responses to metformin through p38-dependent inhibitory AMPK phosphorylation

Doses in research trials have ranged up to 2 mg per kg of body weight per day (max ~50 mg/day) to achieve therapeutic effects [5]

The 2024 study suggests one pathway: if statins lower active GLP-1, the bodys post-meal insulin response and satiety signaling could be blunted, tending toward higher glucose and weightespecially in those with pre-existing insulin resistance